(Total Views: 345)
Posted On: 03/07/2017 12:14:17 PM
Post# of 72447
I just read the Strong Bio article on Stinking-Alpha. I caught the soft-bashing innuendo that Drano mentioned, as well. There was a sort of soft-pumping aspect to the article as well. Brilacidin was highlighted as the star in the CTIX crown, but another thing I noticed was the omittance of a lot of the potential uses for Prurisol, and the offhand mention of Kevetrin as a "p53 enhancer" with anti-(ovarian) cancer application. Hell, once they learn more about how it stimulates/revives the p53 pathway, this could the THE CURE for cancer!
All in all I agree it is a bit of a soft-bashing piece, but not as one sided as most of the others we see on Sucking Alpha. The author took pains to appear as objective and emotionally disengaged as possible, but the overall tone of the article was one of caution and, a not-quite-yet investment sentiment. Why do these fuckers always post from an alias? That, in and of itself, makes me wary of their true intentions!
Quote:
Cellceutix owns the rights to various drug compounds, including Kevetrin (thioureidobutyronitrile), which is its anti-(ovarian) cancer compound; Prurisol (KM-133) which is in development for psoriasis, and Brilacidin, which is its drug in a class of compounds known as defensin-mimetics or antibiotic.
Quote:
According to the company website, Brilacidin and Prurisol are well into phase 2 and Kevetrin, a p53 enhancer, is well into phase 1.
All in all I agree it is a bit of a soft-bashing piece, but not as one sided as most of the others we see on Sucking Alpha. The author took pains to appear as objective and emotionally disengaged as possible, but the overall tone of the article was one of caution and, a not-quite-yet investment sentiment. Why do these fuckers always post from an alias? That, in and of itself, makes me wary of their true intentions!
(1)
(0)
